过去一年中添加的文章,按日期排序

Mitochondrial Proteome Defined Molecular Pathological Characteristics of Oncocytic Thyroid Tumors

L Li, L Zhang, W Jiang, Z Gui, Z Wang, H Zhang… - Endocrine …, 2024 - Springer
4 天前 - … follicular thyroid adenoma (FTA), 21 follicular thyroid carcinoma (… TERT promoter
mutations, which were only detected in OCAs. Previous studies did not analyze the mutations

Association Between Gross Features and Coexistence of BRAFV600E and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis …

TNA Nguyen, VPT Nguyen, H Kurohama, Y Akazawa… - Thyroid, 2024 - liebertpub.com
9 天前 - … The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor
curative effect of radioiodine therapy in papillary thyroid cancer. Eur J Nucl Med Mol Imaging …

Clinically aggressive Follicular Cell-Derived Thyroid Carcinoma: A Comprehensive Series with Histomolecular Characterization and Discovery of Novel Gene Fusions

Z Alsugair, F Descotes, J Lopez, H Lasolle, FB Chazot… - Human Pathology, 2024 - Elsevier
11 天前 - thyroid carcinomas were predominant. The molecular analysis revealed a spectrum
mutations, with prevalent occurrences of BRAF V600E, TERT promoter, and RAS mutations

다양한갑상선암종에서텔로머레이스역전사효소(TERT) 프로모터돌연변이예측인자로서의TERT 와5-하이드록시메틸사이토신면역조직화학의평가

안형록 - 2024 - oak.ulsan.ac.kr
12 天前 - … predictive biomarker for TERT promoter mutation. Materials … TERT mutant group
and 61 patients in TERT wild group) with thyroid carcinoma and the presence of TERT promoter

Molecular prognostication of thyroid tumors: with special focus on TERT

S Hellgren - 2024 - openarchive.ki.se
18 天前 - … In conclusion, ddPCR proved highly effective in detecting TERT promoter mutations
in … to detect TERT promoter mutations in minimally invasive follicular thyroid carcinoma (…

Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular …

E Novis, A Glover, JP Grady, A Silvestri… - Surgery, 2024 - Elsevier
22 天前 - … characterized several oncogenic mutations, allowing a better understanding of why
certain thyroid cancers behave more aggressively. TERT promoter mutations, for instance, …

[HTML][HTML] Aspetti clinici e analisi molecolare delle neoplasie tiroidee a basso rischio: uno studio retrospettivo monocentrico.

L DI LAZZARO - thesis.unipd.it
24 天前 - TERT promoter mutation was evaluated in only 29 patients (33,3%): in 1 case (3,5%)
a pTERT mutation … Conclusions: Based on this study, low-risk thyroid cancers all seem to …

[HTML][HTML] Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules

MY Oh, HM Choi, J Jang, H Son… - Endocrinology and …, 2024 - synapse.koreamed.org
26 天前 - … with high-risk cancers (TERT promoter, PIK3CA, and TP53). … all known mutations
associated with thyroid cancers, as … increase active surveillance of thyroid cancer with low risk …

[HTML][HTML] Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular …

E Steinberg, O Dimitstein, GB Morand, VI Forest… - Cancers, 2024 - mdpi.com
29 天前 - … Methods: This study examined patients with thyroid cancer treated at two tertiary
care hospitals from 2017 to 2024. We compared tumor behavior in patients with TERTp …

6847 Poorly Differentiated Thyroid Cancer: A Rare Entity

S Fatima, S Ward, A Champion - Journal of the Endocrine …, 2024 - academic.oup.com
35 天前 - … in 25–35%, BRAF mutation in 15–27%, TERT promoter mutation in 40% and mutant
TP53 in 16–28% of PDTCs. TERT promoter gene and TP53 mutation usually indicate an …